Unity Biotechnology (NASDAQ:UBX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Unity Biotechnology (UBX) operate in?

Unity Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Unity Biotechnology Stock (NASDAQ: UBX) stock price, news, charts, stock research, profile.

Open	$0.99
Close	$1.00
Volume / Avg.	34.50K / 67.53K
Day Range	$0.98 - $1.00
52 Wk Range	0.95 - 2.02
Market Cap	$16.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	1.55%
Days to Cover	4.88

Recent News

Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution

Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ: UBX) from Neutral to Outperform and

Shivani Kumaresan

Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.99
Close	$1.00
Volume / Avg.	34.50K / 67.53K
Day Range	$0.98 - $1.00
52 Wk Range	0.95 - 2.02
Market Cap	$16.85M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	1.55%
Days to Cover	4.88

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Unity Biotechnology (UBX) stock?

You can purchase shares of Unity Biotechnology (NASDAQ:UBX) through any online brokerage.

View our list of the best stock brokerages

Who are Unity Biotechnology (UBX) competitors?

Other companies in Unity Biotechnology’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Bolt Biotherapeutics (NASDAQ:BOLT) and Geovax Labs (NASDAQ:GOVX).

What is the forecast, or price target, for Unity Biotechnology (UBX) stock?

Unity Biotechnology has a consensus price target of $7.43.

What is the current price for Unity Biotechnology (UBX)?

The stock price for Unity Biotechnology (NASDAQ: UBX) is $0.9999 last updated December 24, 2024 at 4:17 PM EST.

Does Unity Biotechnology (UBX) pay a dividend?

There are no upcoming dividends for Unity Biotechnology.

When is Unity Biotechnology (NASDAQ:UBX) reporting earnings?

Unity Biotechnology’s Q3 earnings are confirmed for Monday, November 4, 2024.

Is Unity Biotechnology (UBX) going to split?

There is no upcoming split for Unity Biotechnology.

What sector and industry does Unity Biotechnology (UBX) operate in?

Unity Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Unity Biotechnology

Unity Biotechnology (UBX) Forecast